v3.26.1
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Balance beginning of period (in shares) at Dec. 31, 2025   0    
Balance beginning of period at Dec. 31, 2025 $ 0 $ 0 $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Proceeds from issuance of common stock (in shares)   5    
Proceeds from public offering of common stock (in shares)   100,619,900    
Proceeds from public offering of common stock 2,012,398 $ 1,006 2,011,392  
Underwriting and offering costs (87,864)   (87,864)  
Grant of restricted stock to non-employee directors pursuant to the stock incentive plan   30,000    
Stock-based compensation 76   76  
Net income $ 7,080     7,080
Balance end of period (in shares) at Jun. 30, 2026 100,649,905 100,649,905    
Balance end of period at Jun. 30, 2026 $ 1,931,690 $ 1,006 1,923,604 7,080
Balance beginning of period (in shares) at Mar. 31, 2026   0    
Balance beginning of period at Mar. 31, 2026 0 $ 0 0 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Proceeds from issuance of common stock (in shares)   5    
Proceeds from public offering of common stock (in shares)   100,619,900    
Proceeds from public offering of common stock 2,012,398 $ 1,006 2,011,392  
Underwriting and offering costs (87,864)   (87,864)  
Grant of restricted stock to non-employee directors pursuant to the stock incentive plan   30,000    
Stock-based compensation 76   76  
Net income $ 7,080     7,080
Balance end of period (in shares) at Jun. 30, 2026 100,649,905 100,649,905    
Balance end of period at Jun. 30, 2026 $ 1,931,690 $ 1,006 $ 1,923,604 $ 7,080